Top

BY Scott Merville

Using an antibody to plug a protein secreted by fibrous tissues in tumors stifles ovarian and pancreatic cancer in mouse models by reducing fibrosis and blood vessel formation, researchers at The University of Texas MD Anderson Cancer Center and Houston Methodist Cancer Center/Houston Methodist Research Institute report in Clinical Cancer Research.

The team also found that the antibody developed to block the microfibril associated...

Researchers have found that targeting the MFAP5 protein in mouse models reduces the fibrosis involved in ovarian and pancreatic cancers.

BY Scott Merville

A slice of RNA that doesn’t code for a protein manages to stifle tumor-suppressing genes and wreck the cellular mechanism that flags cancer...

BY Scott Merville

Combining two types of drugs that, separately, have extended the lives of people with metastatic melanoma has yielded higher response rates...

BY Scott Merville

V. Craig Jordan, Ph.D., professor of Breast Medical Oncology, has been recognized for his “services to women’s health” with his appointment by Queen Elizabeth II as a Companion (CMG) of the Most Distinguished Order of St. Michael and St. George, announced June 7 as part of the Queen’s Birthday Honours list tradition in the United Kingdom.

It’s the latest honor for Jordan’s discovery and development of selective estrogen receptor...

V. Craig Jordan, Ph.D.

BY Scott Merville

Improvements in breast cancer treatment over the past five decades have reduced the mortality rate of women with the disease by 40 percent...

BY Scott Merville

MD Anderson researchers will present clinical trial results of promising combination therapies for a variety of cancers at the 2019 American...

BY Scott Merville

Nobel Laureate Jim Allison, Ph.D., invented immune checkpoint blockade immunotherapy by blocking the CTLA-4 protein on T cells, freeing those...

BY Scott Merville

As his first official act of Nobel Week, 2018 Nobel Laureate in Physiology or Medicine Jim Allison, Ph.D., on Thursday signed the bottom of...

BY Scott Merville

Lung cancer immunotherapy triggers a counterattack by a surface protein found on the tumors of some patients that stifles the immune system...

BY Scott Merville

MD Anderson researchers have uncovered a genetic condition that thwarts the most common immunotherapy used against lung cancer, opening new...